Lixte Biotechnology Holdings Inc (LIXT)
1.63
+0.11
(+7.24%)
USD |
NASDAQ |
Nov 22, 16:00
1.69
+0.06
(+3.68%)
After-Hours: 20:00
Lixte Biotechnology Holdings Free Cash Flow: -3.468M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.468M |
| June 30, 2024 | -3.455M |
| March 31, 2024 | -3.811M |
| December 31, 2023 | -4.293M |
| September 30, 2023 | -4.600M |
| June 30, 2023 | -4.829M |
| March 31, 2023 | -4.848M |
| December 31, 2022 | -4.612M |
| September 30, 2022 | -4.550M |
| June 30, 2022 | -4.304M |
| March 31, 2022 | -4.152M |
| December 31, 2021 | -4.143M |
| September 30, 2021 | -3.735M |
| June 30, 2021 | -3.431M |
| March 31, 2021 | -2.744M |
| December 31, 2020 | -2.131M |
| September 30, 2020 | -1.770M |
| June 30, 2020 | -1.734M |
| March 31, 2020 | -1.709M |
| December 31, 2019 | -1.674M |
| September 30, 2019 | -1.873M |
| June 30, 2019 | -1.450M |
| March 31, 2019 | -1.393M |
| December 31, 2018 | -1.511M |
| September 30, 2018 | -1.219M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.514M |
| March 31, 2018 | -1.581M |
| December 31, 2017 | -1.412M |
| September 30, 2017 | -1.598M |
| June 30, 2017 | -1.617M |
| March 31, 2017 | -1.681M |
| December 31, 2016 | -1.677M |
| September 30, 2016 | -1.820M |
| June 30, 2016 | -1.849M |
| March 31, 2016 | -1.968M |
| December 31, 2015 | -2.181M |
| September 30, 2015 | -2.213M |
| June 30, 2015 | -2.042M |
| March 31, 2015 | -1.815M |
| December 31, 2014 | -1.636M |
| September 30, 2014 | -1.307M |
| June 30, 2014 | -1.254M |
| March 31, 2014 | -1.259M |
| December 31, 2013 | -1.180M |
| September 30, 2013 | -1.090M |
| June 30, 2013 | -1.101M |
| March 31, 2013 | -1.237M |
| December 31, 2012 | -1.206M |
| September 30, 2012 | -1.546M |
| June 30, 2012 | -1.654M |
Free Cash Flow Range, Past 5 Years
-4.848M
Minimum
Mar 2023
-1.674M
Maximum
Dec 2019
-3.500M
Average
-3.773M
Median
Free Cash Flow Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -5.699M |
| Soligenix Inc | -7.999M |
| Tonix Pharmaceuticals Holding Corp | -69.19M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.9576M |
| Free Cash Flow Per Share (Quarterly) | -0.4257 |
| Free Cash Flow Yield | -94.55% |